Articles and Blogs

Year: 2020

NLRB Issues New Joint Employer Rule: How Are Some Hospitals and Health Systems Impacted?

[03/02/20]

Posted on March 2, 2020 in Health Law News

Published by: Hall Render

On February 26, 2020, the National Labor Relations Board issued its final rule establishing the standard for determining whether two employers are joint employers under the Act (“New Rule”). History of Joint Employer Standard As explained by the NLRB, a joint employer finding has significant implications for rights and obligations under the NLRA relative... READ MORE

Tags: , , ,

Hall Render’s The Week in Washington – March 2, 2020

[03/02/20]

Posted on March 2, 2020 in Federal Advocacy

Published by: Hall Render

Supreme Court Agrees to Hear ACA Validity Case Today, the Supreme Court agreed to hear a third major Affordable Care Act (“ACA”) case. The Court will consider whether a legislative change to the ACA’s individual mandate rendered the landmark law unconstitutional. Learn more from a recent Hall Render article here. By granting petitions from... READ MORE

Tags: , , , , ,

Deadlines Matter in Wage Index Case

[02/28/20]

Posted on February 28, 2020 in Health Law News

Published by: Hall Render

On February 11, 2020, the U.S. Court of Appeals for the District of Columbia (D.C.) Circuit upheld the decision of a lower court granting summary judgment in favor of the Secretary of the Department of Health and Human Services (“HHS”) in a wage index calculation Medicare reimbursement case. The Court held that the Secretary’s... READ MORE

Tags: , , , ,

Health Provider News – February 28, 2020

[02/28/20]

Posted on February 28, 2020 in Health Law News

Published by: Hall Render

NATIONAL 10 digital health tools driving the biggest ROI for hospitals AMA Reviews Patient Data Access Under HIPAA Regulations Amazon most mentioned among emerging health IT companies, KLAS finds C.D.C. Officials Warn of Coronavirus Outbreaks in the U.S. CMS pitches expanding bundled payments for joint replacements CMS Seeks Extension for Comprehensive Care for Joint... READ MORE

FDA Revisits Unsubstantiated Claims Surrounding Pharmacogenetic Testing

[02/26/20]

Posted on February 26, 2020 in Health Law News

Published by: Hall Render

Pharmacogenetic Testing and the FDA’s 2018 Warning The advent of direct-to-consumer genetic testing has yielded an explosion in the development of various types of genetic tests for clinical treatment and diagnostic purposes. These tests include pharmacogenetic tests, which are used to better understand the role genetics play in an individual patient’s reaction to certain... READ MORE

Tags: , , , ,

Novel Coronavirus 2019-nCoV and FDA’s Emergency Use Authorization Authority

[02/26/20]

Posted on February 26, 2020 in Health Law News

Published by: Hall Render

It is no secret why the novel coronavirus (“2019-nCoV”) outbreak in Wuhan City, Hubei Province, China quickly raised health concerns on an international scale. The coronavirus family contains member viruses with a similarly sinister and deadly past; viruses that seemingly appeared out of nowhere and rapidly spread. For example, two betacoronaviruses were the culprits... READ MORE

Tags: , , , , , , ,

CMS Proposed Rule Extends and Revises Comprehensive Care for Joint Replacement Program

[02/26/20]

Posted on February 26, 2020 in Health Law News

Published by: Hall Render

On February 20, 2020, the Centers for Medicare & Medicaid Services (“CMS”) issued proposed revisions (“Proposed Rule”) to the regulations governing the Comprehensive Care for Joint Replacement (“CJR”) program. Among other things, the Proposed Rule would extend mandatory participation in the CJR program an additional three years for certain current participants, revise the reconciliation... READ MORE

Tags: , , , ,

Previously Settled FCA Case Resurrected by New “Original Source” Relator

[02/25/20]

Posted on February 25, 2020 in False Claims Act Defense

Published by: Hall Render

The United States Court of Appeals for the First Circuit issued an opinion creating a national divide on when a relator is an “original source” of an FCA claim, finding that a relator’s secondhand knowledge of fraud was “direct” knowledge. Facts of the Case In United States ex rel. Banigan v. PharMerica, Inc.[1], a... READ MORE

Tags: ,

Hall Render’s The Week in Washington – February 24, 2020

[02/24/20]

Posted on February 24, 2020 in Federal Advocacy

Published by: Hall Render

Congress returns this week after its President’s Day district work period. HHS Secretary Azar is testifying before four different congressional committees on the administration’s Fiscal Year (“FY”) 2021 budget request. Also, the White House is expected to submit a formal request for emergency funding for the Coronavirus. The funding is unlikely to become a... READ MORE

Health Provider News – February 21, 2020

[02/21/20]

Posted on February 21, 2020 in Health Law News

Published by: Hall Render

NATIONAL 7 alerts, tools hospitals are adding to their EHRs CMS rule gives Part D plans, PBMs new negotiation tools with drug companies From Data to AI: How these 4 tech trends are reshaping healthcare Medicare spent $41M+ on sepsis in 2018, HHS says Ob-gyns get AMA help to redesign residency application process Private... READ MORE